knowledge -WSS

knowledge

author：fashion 2025-09-03 11:52:59 - browse：27653

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Stopping antidepressants leads to symptoms for 1 in 6 patients

WSS

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

The FDA must approve intranasal treatments for anaphylaxis

New weight loss drugs work. But how can they best be used?

J&J to buy cancer drug developer Ambrx Biopharma

JPM: CVS says Medicare Advantage patients are impacting profits

UCB departs biotech trade group BIO

entertainment

knowledge

knowledge

At least 13 dead in Texas as scorching temps continue

Federal weight loss drug coverage is 30 years out of date

United colonoscopy coverage change 'may cost lives,' doctors say

GSK Flovent asthma inhalers replaced by authorized generics

Anesthesiologist group: stop taking Ozempic before surgery

STAT wants to know your pick for a great summer read or listen

How to save PrEP access — and even expand it

AdventHealth escalates lawsuit against insurance vendor Multiplan

Virginia high school admissions case could be legal follow

The most pressing bird flu mysteries scientists want answered

hotspot

STAT wants to know your pick for a great summer read or listen

Anthony Fauci pushes back on GOP claims during Covid hearing

The most pressing bird flu mysteries scientists want answered

Chronically ill young patients struggle to find fertility info

The biotech scorecard for Q1: 17 stock

Medicare Advantage's lean provider networks lead CMS complaints

entertainment

focus

Wikipedia

focus